Oaktree Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Oaktree Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$42K	–	370
2021 Q4	$42K	Buy	+100,000	New	+$46.1K	﹤0.01%	361

Other funds holding CEROW

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return